Asia-Pacific Interventional Neurology Devices Market - Industry Trends and Forecast to 2029

Market Analysis and Insights : Asia-Pacific Interventional Neurology Devices Market

The interventional neurology devices market is expected to witness market growth at a rate of 15.1% in the forecast period of 2022 to 2029. Data Bridge Market Research report on interventional neurology devices market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The rise in the aviation sector is escalating the growth of interventional neurology devices market.

Interventional neurology devices are used to treat neurovascular illnesses such as arteriovenous malformations, aneurysms, stroke and cavernous malformations using non-invasive and image guided treatments.

The prevalence of neurological disorders such as Alzheimer's disease, cerebrovascular diseases such as stroke, migraine, and other headache disorders is increasing, resulting in greater demand for the product and boosting the growth of interventional neurology devices. Large target patient populations, high stress levels in young people and head injuries, and increasing market demand for effective neurovascular devices are the primary factors driving the target market's growth. Furthermore, rapid geriatric population growth, ongoing product development and commercialization, expansion of healthcare infrastructure across emerging markets, and favourable medical reimbursements are the major drivers that will enhance the growth of interventional neurology devices market.

Moreover, upsurge in the demand for minimally invasive neurosurgical procedures and growing research activities for neurovascular therapies will provide beneficial opportunities for the interventional neurology devices market growth.

However, the dearth of skilled neurologists and strict government regulations are the factors that will obstruct the market growth. Also, high procedure cost and lack of favourable reimbursement policies will challenge the interventional neurology devices market.  

This interventional neurology devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on interventional neurology devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Asia-Pacific Interventional Neurology Devices Market Scope and Market Size

The interventional neurology devices market is segmented on the basis of product type, disease pathology, procedure and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• Based on product type, the interventional neurology devices market is segmented into aneurysm coiling and embolization devices, cerebral balloon angioplasty and stenting systems, support devices and neurothrombectomy devices. Aneurysm coiling and embolization devices segment is further sub-segmented into embolic coils, flow diversion devices and liquid embolic agents. Embolic coils are divided into bare detachable coils and coated detachable coils. Cerebral balloon angioplasty and stenting systems segment is further sub-segmented into carotid artery stents and embolic protection systems. Embolic protection systems are divided into distal filter devices and balloon occlusion devices. Support devices segment is further sub-segmented into micro guidewires and microcatheters. Neurothrombectomy devices segment is further sub-segmented into CLOT retrieval devices, suction and aspiration devices and snares.
• On the basis of disease pathology, the interventional neurology devices market is segmented into ischemic strokes, cerebral aneurysms, arteriovenous malformation and fistulas and others.
• On the basis of procedure, the interventional neurology devices market is segmented into embolization, angioplasty, neurothrombectomy and others.
• Based on end user, the interventional neurology devices market is segmented into hospitals, neurology clinics, ambulatory care centers and others.

Interventional Neurology Devices Market Country Level Analysis

The interventional neurology devices market is analysed and market size insights and trends are provided by country, product type, disease pathology, procedure and end user as referenced above.

The countries covered in the interventional neurology devices market report are Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific.

Japan dominates the interventional neurology devices market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and large target patient populations in this region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the improving healthcare infrastructure and rising awareness among neurosurgeons about the benefits associated with interventional neurology devices in this region.

The country section of the interventional neurology devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The interventional neurology devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for interventional neurology devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the interventional neurology devices market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Global Interventional Neurology Devices Market Share Analysis

The interventional neurology devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to interventional neurology devices market.

Some of the major players operating in the interventional neurology devices market are Johnson & Johnson Private Limited, Abbott, Boston Scientific Corporation, Stryker, Medtronic, Terumo Corporation, Penumbra, Inc., MicroPort Scientific Corporation, Merit Medical Systems, W.L. Gore & Associates, Inc., B. Braun Melsungen AG, UreSil, LLC, Medikit co., ltd., Bayer AG, Acandis GmbH, Biosensors International Group, Ltd., Medical Devices Business Services, Inc., Surtex Instruments Limited, Cook, LivaNova PLC, and Integra LifeSciences, among others.

SKU-1562